Now showing items 1-20 of 21

      Subject
      Harmaline, Harmalol, Harmine, Ileum, Peganum Hermala L, Rat, Spasmolytic, β-Carbolines alkaloids [1]
      Health policy, Health services research, Pharmaco-economics [1]
      health services research, patient satisfaction, pharmaceutical HSR, quality of care, quality of life [1]
      Health-related quality of life, Heart failure, Intervention, Jordan, Minnesota living with heart failure questionnaire [1]
      Healthcare services Health coaching, Pharmacist-based health coaching, Women health [1]
      Healthcare, Patients, Satisfaction, Service Quality, Social Media, UAE [1]
      Heart failure with reduced ejection fraction (HFrEF), hydralazine, hydralazine-nitrate, isosorbide dinitarte, New York Heart Association (NYHA), randomized clinical trials, the Vasodilator Heart Failure Trial II (V-HeFT II), Vasodilator Heart Failure Trial I (V-HeFT I) [1]
      herbal medicine usage, natural ingredients, UAE [1]
      Herbal medicines, Jordan, Attitude, Prevalence, Risk factors [1]
      high-ability learners, Mathematics Enrichment Program, PISA, problem solving, students’ [1]
      Hindmarsh-rose model, image encryption, parallel computing, SHA-256 [1]
      Hospital pharmacist, Pharmacists, Pharmacy Service, Pakistan [1]
      Human capital development, Minimum wage [1]
      Human concept, human rights, Islamic thought, global thought [1]
      Human object interaction, Human pose estimation, Object detection, Sports estimation, Sports prediction [1]
      Human–Computer Interaction, Artificial Intelligence, Computer Vision, Data Mining and Machine Learning, Multimedia [1]
      Hybrid nanofluid, synthesized, microorganism, energy stabilization, spinning of cone, nanoparticulate, base fluid, modeled problem, Magnesium oxide [1]
      Hybrid nanoparticles , hyperbolic tangent material, thermal transportation, Cattaneo-Christov flux, heat, (MoS2/Ag), heat transport [1]
      Hydrogel, Pectin, Polymer synthesis, Topical [2]
      Hyperlipidemia, Dyslipidemia, ATP-III guideline, ACC/AHA guideline, Comparison, Cardiovascular risk [1]